BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25609660)

  • 21. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune hemolysis due to piperacillin/tazobactam.
    Garcia Gala JM; Vazquez Aller S; Rodriguez Vicente P; Morante Pombo C
    Transfus Apher Sci; 2009 Apr; 40(2):97-8. PubMed ID: 19250872
    [No Abstract]   [Full Text] [Related]  

  • 23. Cystic Fibrosis and Piperacillin-tazobactam: Adverse Reactions.
    Diab Cáceres L; Marcos MC; Girón Moreno RM
    Arch Bronconeumol; 2015 Dec; 51(12):664-5. PubMed ID: 25929193
    [No Abstract]   [Full Text] [Related]  

  • 24. Piperacillin/tazobactam-induced paresthesiae.
    Lambourne J; Kitchen J; Hughes C; Merry C
    Ann Pharmacother; 2006 May; 40(5):977-9. PubMed ID: 16622157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piperacillin-tazobactam-induced drug hypersensitivity syndrome.
    Fahim S; Jain V; Victor G; Pierscianowski T
    Cutis; 2006 Jun; 77(6):353-7. PubMed ID: 16838767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute generalized exanthematous pustulosis caused by piperacillin/tazobactam.
    Grieco T; Cantisani C; Innocenzi D; Bottoni U; Calvieri S
    J Am Acad Dermatol; 2005 Apr; 52(4):732-3. PubMed ID: 15793550
    [No Abstract]   [Full Text] [Related]  

  • 27. De novo generalised non-convulsive status epilepticus triggered by piperacillin/tazobactam.
    Fernández-Torre JL; Santos-Sánchez C; Pelayo AL
    Seizure; 2010 Oct; 19(8):529-30. PubMed ID: 20674399
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute localized exanthematous pustulosis on inguinal area secondary to piperacillin/tazobactam.
    Huilaja L; Kallioinen M; Soronen M; Riekki R; Tasanen K
    Acta Derm Venereol; 2014 Jan; 94(1):106-7. PubMed ID: 23817479
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug fever due to piperacillin/tazobactam loaded into bone cement.
    Park HB; Choi JS; Park SH; Kee WJ; Koh YI
    J Korean Med Sci; 2011 Feb; 26(2):301-3. PubMed ID: 21286026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug fever caused by piperacillin-tazobactam.
    Linares T; Fernández A; Soto MT; Escudero E; Gacías L
    J Investig Allergol Clin Immunol; 2011; 21(3):250-1. PubMed ID: 21548459
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet Dysfunction and Intracerebral Hemorrhage in a Patient Treated with Empiric Piperacillin-Tazobactam in the Neurocritical Care Unit.
    Bower M; Borders C; Schnure A; Groysman L; Tran MH
    World Neurosurg; 2018 Jun; 114():204-210. PubMed ID: 29555607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperacillin/tazobactam-induced myoclonic jerks in a man with chronic renal failure.
    Man BL; Fu YP
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25956160
    [No Abstract]   [Full Text] [Related]  

  • 33. Piperacillin-Tazobactam Induced Interstitial Nephritis, Hepatitis and Serum Sckness-Like Illness.
    Kraleti S; Khatri N; Jarrett D
    J Ark Med Soc; 2016 Jun; 112(14):278-80. PubMed ID: 27434982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report.
    Calogiuri GF; Nettis E; Di Leo E; Vacca A; Ferrannini A; Kounis NG
    Int J Cardiol; 2012 Mar; 155(3):e42-4. PubMed ID: 21839530
    [No Abstract]   [Full Text] [Related]  

  • 35. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
    LeClaire AC; Martin CA; Hoven AD
    Ann Pharmacother; 2004 Jun; 38(6):996-8. PubMed ID: 15113982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report.
    Roh S; Hashimoto K; Kiriishi R; Matsubara K; Isozaki Y; Tanaka H; Kuwata T
    J Wound Care; 2024 Jun; 33(Sup6):S25-S30. PubMed ID: 38843043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
    Gomes DM; Smotherman C; Birch A; Dupree L; Della Vecchia BJ; Kraemer DF; Jankowski CA
    Pharmacotherapy; 2014 Jul; 34(7):662-9. PubMed ID: 24753221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin.
    Finsterer J; Kotzailias N
    Platelets; 2003 Aug; 14(5):329-31. PubMed ID: 12944250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
    Giuliano CA; Patel CR; Kale-Pradhan PB
    Pharmacotherapy; 2016 Dec; 36(12):1217-1228. PubMed ID: 27805728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.
    Charoenpong L; Tongsai S; Thamlikitkul V
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S104-10. PubMed ID: 23590029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.